BioPharma Resources

Free tool

FAERS Monitor: Keytruda

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125514 or its brand name (Keytruda, Pembrolizumab). Reports on generic versions are filed under their own applications.

Reports

108,520

Serious

95,155

88% of reports

Hospitalization

45,600

Death reported

19,320

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression12,384
  • death6,043
  • diarrhoea5,920
  • fatigue5,236
  • off label use4,866
  • pyrexia4,018
  • rash3,883
  • nausea3,672
  • product use in unapproved indication3,594
  • decreased appetite3,399
  • hypertension3,339
  • hypothyroidism3,041
  • asthenia2,865
  • drug ineffective2,660
  • interstitial lung disease2,630

Reports by year received

View as table
YearReports
20121
20131
2014597
20151,281
20162,323
20174,119
20184,867
20196,374
20206,810
20218,400
202212,623
202315,880
202416,087
202517,374
202611,783

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,945,639 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
malignant neoplasm progressionSignal12,38426.526.1268,673
hypothyroidismSignal3,04120.319.650,536
interstitial lung diseaseSignal2,63011.110.722,837
hypertensionSignal3,3393.13.04,686
decreased appetiteSignal3,3992.92.84,105
product use in unapproved indicationSignal3,5942.82.74,262
pyrexiaSignal4,0182.32.22,852
diarrhoea5,9201.81.72,087
rash3,8831.71.71,218
asthenia2,8651.51.4451
death6,0431.41.3602
fatigue5,2361.31.3386
off label use4,8661.11.028
nausea3,6720.90.943
drug ineffective2,6600.40.42,702

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.